Dichorionic twin-specific vs singleton growth references for diagnosis of fetal growth restriction

Sarah K Shea1, Benjamin J Likins1, Andrea D Boan2

  • 1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Medical University of South Carolina, Charleston, SC.

Insights

The Eunice Kennedy Shriver National Institute of Child Health and Human Development

Area of Science:

  • Perinatal medicine
  • Neonatal outcomes
  • Maternal-fetal medicine

Background:

  • Fetal growth restriction (FGR) in twins increases neonatal risks.
  • The Hadlock singleton reference is commonly used, but twin growth differs.
  • A twin-specific reference (NICHD) exists, but comparative research is limited.

Purpose of the Study:

  • To compare the Hadlock singleton and NICHD twin-specific growth references.
  • To assess their ability to identify FGR associated with adverse neonatal outcomes in dichorionic twins.

Main Methods:

  • Retrospective cohort study of dichorionic twins (≥32 weeks gestation).
  • Compared FGR classification using Hadlock vs. NICHD references (estimated fetal weight <10th percentile).
  • Multivariable models assessed adverse neonatal outcomes, accounting for twin correlation.

Main Results:

  • 1460 infants included; 8.1% had FGR by both references, 8.8% by Hadlock only.
  • FGR by both references was linked to higher mild/severe neonatal morbidity.
  • Hadlock-only FGR did not show increased morbidity compared to no FGR.

Conclusions:

  • The NICHD twin-specific reference better identifies FGR risk for adverse neonatal outcomes.
  • The Hadlock reference overestimates FGR in twins, potentially causing unnecessary interventions and anxiety.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K